An Overview of FGF-23 as a Novel Candidate Biomarker of Cardiovascular Risk
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An Overview of FGF-23 as a Novel Candidate Biomarker of Cardiovascular Risk
Authors
Keywords
-
Journal
Frontiers in Physiology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-03-09
DOI
10.3389/fphys.2021.632260
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- FGF-23 correlates with endocrine and metabolism dysregulation, worse cardiac and renal function, inflammation level, stenosis degree, and independently predicts in-stent restenosis risk in coronary heart disease patients underwent drug-eluting-stent PCI
- (2021) Tingting Song et al. BMC Cardiovascular Disorders
- Association between plasma fibroblast growth factor 23 and left ventricular mass index in patients with Takayasu arteritis
- (2020) Nan Cheng et al. CLINICAL RHEUMATOLOGY
- Exendin-4 Reduces Ventricular Arrhythmia Activity and Calcium Sparks-Mediated Sarcoplasmic Reticulum Ca Leak in Rats with Heart Failure
- (2020) Jingjing Chen et al. International Heart Journal
- Kidney transplantation improves arterial stiffness in patients with end-stage renal disease
- (2020) Sujuan Feng et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Racial Differences in the Associations Between Food Insecurity and Fibroblast Growth Factor 23 in the Coronary Artery Risk Development in Young Adults Study
- (2020) Lindsay R. Pool et al. JOURNAL OF RENAL NUTRITION
- Fibrosis growth factor 23 is a promoting factor for cardiac fibrosis in the presence of transforming growth factor-β1
- (2020) Kazuhiro Kuga et al. PLoS One
- Positive correlation of serum fibroblast growth factor 23 with peripheral arterial stiffness in kidney transplantation patients
- (2020) Yao-Chang Liu et al. CLINICA CHIMICA ACTA
- Multi-proteomic approach to predict specific cardiovascular events in patients with diabetes and myocardial infarction: findings from the EXAMINE trial
- (2020) João Pedro Ferreira et al. Clinical Research in Cardiology
- Fibroblast growth factor 23: a biomarker of fibrosis and prognosis in heart failure with preserved ejection fraction
- (2020) Clotilde Roy et al. ESC Heart Failure
- Enhanced Klotho availability protects against cardiac dysfunction induced by uraemic cardiomyopathy by regulating Ca 2+ handling
- (2020) José Alberto Navarro‐García et al. BRITISH JOURNAL OF PHARMACOLOGY
- Intact and C-Terminal FGF23 Assays—Do Kidney Function, Inflammation, and Low Iron Influence Relationships With Outcomes?
- (2020) Shilpa Sharma et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Sprint and endurance training in relation to redox balance, inflammatory status and biomarkers of aging in master athletes
- (2020) Thiago Santos Rosa et al. NITRIC OXIDE-BIOLOGY AND CHEMISTRY
- Fibroblast‐growth‐factor‐23 in heart failure with preserved ejection fraction: relation to exercise capacity and outcomes
- (2020) Prathap Kanagala et al. ESC Heart Failure
- Metabolic Changes in Spontaneously Hypertensive Rat Hearts Precede Cardiac Dysfunction and Left Ventricular Hypertrophy
- (2019) Jie Li et al. Journal of the American Heart Association
- Plasmatic Klotho and FGF23 Levels as Biomarkers of CKD-Associated Cardiac Disease in Type 2 Diabetic Patients
- (2019) Ana Silva et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cardiac FGF23: new insights into the role and function of FGF23 after acute myocardial infarction
- (2019) David Schumacher et al. CARDIOVASCULAR PATHOLOGY
- Proteomic Bioprofiles and Mechanistic Pathways of Progression to Heart Failure
- (2019) João Pedro Ferreira et al. Circulation-Heart Failure
- Soluble klotho regulates TRPC6 calcium signaling via lipid rafts, independent of the FGFR-FGF23 pathway
- (2019) Jon D. Wright et al. FASEB JOURNAL
- FGF23 regulates atrial fibrosis in atrial fibrillation by mediating the STAT3 and SMAD3 pathways
- (2019) Quanbin Dong et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Multifaceted Mechanisms of Vascular Calcification in Aging
- (2019) Luciana A. Pescatore et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Biomarkers of mineral metabolism and progression of aortic valve and mitral annular calcification: The Multi-Ethnic Study of Atherosclerosis
- (2019) Anna E. Bortnick et al. ATHEROSCLEROSIS
- Efficacy of de‐escalated chemotherapy according to PAM50 subtypes, immune and proliferation genes in triple‐negative early breast cancer: Primary translational analysis of the WSG‐ADAPT‐TN trial
- (2019) Oleg Gluz et al. INTERNATIONAL JOURNAL OF CANCER
- Recombinant α-Klotho Protein Alleviated Acute Cardiorenal Injury in a Mouse Model of Lipopolysaccharide-Induced Septic Cardiorenal Syndrome Type 5
- (2019) Xi Liu et al. Analytical Cellular Pathology
- Fibroblast growth factor 23 expression in human calcified vascular tissues
- (2019) Javier Donate-Correa et al. Aging-US
- FGF23-Mediated Activation of Local RAAS Promotes Cardiac Hypertrophy and Fibrosis
- (2019) Ineke Böckmann et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Chronic Kidney Disease as a Risk Factor for Heart Failure With Preserved Ejection Fraction: A Focus on Microcirculatory Factors and Therapeutic Targets
- (2019) Jens van de Wouw et al. Frontiers in Physiology
- Impact of race on the association of mineral metabolism with heart failure: the Multi-Ethnic Study of Atherosclerosis
- (2019) Cassianne Robinson-Cohen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- FGFR4 does not contribute to progression of chronic kidney disease
- (2019) Ashlee Taylor et al. Scientific Reports
- FGF23 induced left ventricular hypertrophy mediated by FGFR4 signaling in the myocardium is attenuated by soluble Klotho in mice
- (2019) Xiaobin Han et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Diabetes, cardiovascular disease and the microcirculation
- (2018) W. David Strain et al. Cardiovascular Diabetology
- Changes in Serum Fibroblast Growth Factor 23 in Patients With Acute Myocardial Infarction
- (2018) Hideaki Takahashi et al. CIRCULATION JOURNAL
- PTH, vitamin D, and the FGF-23-klotho axis and heart: Going beyond the confines of nephrology
- (2018) José Alberto Navarro-García et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Fibroblast growth factor 23 is related to profiles indicating volume overload, poor therapy optimization and prognosis in patients with new-onset and worsening heart failure
- (2018) Jozine M. ter Maaten et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Clinical implication of alterations in serum Klotho levels in patients with type 2 diabetes mellitus and its associated complications
- (2018) Lingling Zhang et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Fibroblast Growth Factor-23 and Risks of Cardiovascular and Noncardiovascular Diseases: A Meta-Analysis
- (2018) Amarnath Marthi et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Fibroblast growth factor 23 is induced by an activated renin–angiotensin–aldosterone system in cardiac myocytes and promotes the pro-fibrotic crosstalk between cardiac myocytes and fibroblasts
- (2018) Maren Leifheit-Nestler et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Paracrine Effects of FGF23 on the Heart
- (2018) Maren Leifheit-Nestler et al. Frontiers in Endocrinology
- Impact of Altered Mineral Metabolism on Pathological Cardiac Remodeling in Elevated Fibroblast Growth Factor 23
- (2018) Maren Leifheit-Nestler et al. Frontiers in Endocrinology
- Phosphate control in reducing FGF23 levels in hemodialysis patients
- (2018) Cristian Rodelo-Haad et al. PLoS One
- Blocking FGFR4 exerts distinct anti-tumorigenic effects in esophageal squamous cell carcinoma
- (2018) Zhongwei Xin et al. Thoracic Cancer
- Fibroblast Growth Factor‐23 and Heart Failure With Reduced Versus Preserved Ejection Fraction: MESA
- (2018) Mohamed Faher Almahmoud et al. Journal of the American Heart Association
- Structure, activation and dysregulation of fibroblast growth factor receptor kinases: perspectives for clinical targeting
- (2018) Brendan Farrell et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Data-driven discovery and validation of circulating blood-based biomarkers associated with prevalent atrial fibrillation
- (2018) Winnie Chua et al. EUROPEAN HEART JOURNAL
- Fibroblast growth factor-23 promotes rhythm alterations and contractile dysfunction in adult ventricular cardiomyocytes
- (2018) José Alberto Navarro-García et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- The association of chronic kidney disease and microalbuminuria with heart failure with preserved vs. reduced ejection fraction
- (2017) Matthew Nayor et al. EUROPEAN JOURNAL OF HEART FAILURE
- Head to head comparison of intact and C-terminal fibroblast growth factor 23 in heart failure patients with reduced ejection fraction
- (2017) Damien Gruson et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Fibroblast Growth Factor 23, Mineral Metabolism, and Adiposity in Normal Kidney Function
- (2017) Sarah Zaheer et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The effect of PKA-mediated phosphorylation of ryanodine receptor on SR Ca2+ leak in ventricular myocytes
- (2017) Elisa Bovo et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Ablation of the cardiac ryanodine receptor phospho-site Ser2808 does not alter the adrenergic response or the progression to heart failure in mice. Elimination of the genetic background as critical variable
- (2017) Francisco J. Alvarado et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Association between Soluble Klotho and Change in Kidney Function: The Health Aging and Body Composition Study
- (2017) David A. Drew et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Recombinant α-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy
- (2017) Ming Chang Hu et al. KIDNEY INTERNATIONAL
- FGF23/FGFR4-mediated left ventricular hypertrophy is reversible
- (2017) Alexander Grabner et al. Scientific Reports
- Genetic Ablation of Fgf23 or Klotho Does not Modulate Experimental Heart Hypertrophy Induced by Pressure Overload
- (2017) Svetlana Slavic et al. Scientific Reports
- Fibroblast growth factor 23 as novel biomarker for early risk stratification after ST-elevation myocardial infarction
- (2016) Martin Reindl et al. HEART
- Fibroblast Growth Factor-23 (FGF-23) Levels Differ Across Populations by Degree of Industrialization
- (2016) Shennin N. Yuen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Fibroblast Growth Factor 23 and Cause-Specific Mortality in the General Population: The Northern Manhattan Study
- (2016) Nao Souma et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- PTH signaling mediates perilacunar remodeling during exercise
- (2016) Joseph D. Gardinier et al. MATRIX BIOLOGY
- Epidemiology and aetiology of heart failure
- (2016) Boback Ziaeian et al. Nature Reviews Cardiology
- Extrarenal effects of FGF23
- (2016) Dieter Haffner et al. PEDIATRIC NEPHROLOGY
- Role of fibroblast growth factor 23 in the development of cardiovascular diseases in patients with end-stage renal failure on programmed hemodialysis
- (2016) F. U. Dzgoeva et al. TERAPEVTICHESKII ARKHIV
- FGF23 promotes myocardial fibrosis in mice through activation of β-catenin
- (2016) Huixin Hao et al. Oncotarget
- FGF23-FGF Receptor/Klotho Pathway as a New Drug Target for Disorders of Bone and Mineral Metabolism
- (2015) Seiji Fukumoto CALCIFIED TISSUE INTERNATIONAL
- Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy
- (2015) Alexander Grabner et al. Cell Metabolism
- Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in HemodialysisCLINICAL PERSPECTIVE
- (2015) Sharon M. Moe et al. CIRCULATION
- Fibroblast Growth Factor 23 Is an Independent and Specific Predictor of Mortality in Patients With Heart Failure and Reduced Ejection Fraction
- (2015) Lorenz Koller et al. Circulation-Heart Failure
- Experimental Myocardial Infarction Upregulates Circulating Fibroblast Growth Factor-23
- (2015) Olena Andrukhova et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Prolonged Correction of Serum Phosphorus in Adults With X-Linked Hypophosphatemia Using Monthly Doses of KRN23
- (2015) Erik A. Imel et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Reconciling depressed Ca2+sparks occurrence with enhanced RyR2 activity in failing mice cardiomyocytes
- (2015) Gema Ruiz-Hurtado et al. JOURNAL OF GENERAL PHYSIOLOGY
- Low Vitamin D and High Fibroblast Growth Factor 23 Serum Levels Associate with Infectious and Cardiac Deaths in the HEMO Study
- (2015) M. Chonchol et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Key role of the kidney in the regulation of fibroblast growth factor 23
- (2015) Maria L. Mace et al. KIDNEY INTERNATIONAL
- Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease
- (2015) Maren Leifheit-Nestler et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Elevation of circulating but not myocardial FGF23 in human acute decompensated heart failure
- (2015) Ingrid A. Andersen et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- The PTH-Vitamin D-FGF23 axis
- (2015) Jenny E. Blau et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Fibroblast Growth Factor 23 and Risk of Incident Stroke in Community-Living Adults
- (2015) Bhupesh Panwar et al. STROKE
- Low Magnesium Levels and FGF-23 Dysregulation Predict Mitral Valve Calcification as well as Intima Media Thickness in Predialysis Diabetic Patients
- (2015) Ana Paula Silva et al. International Journal of Endocrinology
- Association of Fibroblast Growth Factor-23 Levels and Angiotensin-Converting Enzyme Inhibition in Chronic Systolic Heart Failure
- (2015) Peter Wohlfahrt et al. JACC-Heart Failure
- Fibroblast growth factor 23 (FGF23) and mortality: The Ludwigshafen Risk and Cardiovascular Health Study
- (2014) Vincent M. Brandenburg et al. ATHEROSCLEROSIS
- Fibroblast Growth Factor-23 and Incident Atrial Fibrillation
- (2014) Jehu S. Mathew et al. CIRCULATION
- Fibroblast Growth Factor-23 and Cardiovascular Disease in the General Population
- (2014) Bryan Kestenbaum et al. Circulation-Heart Failure
- FGF-23 dysregulates calcium homeostasis and electrophysiological properties in HL-1 atrial cells
- (2014) Yu-Hsun Kao et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- FGF23 is associated with disease severity and prognosis in chronic heart failure
- (2014) Gerhard Poelzl et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Plasma fibroblast growth factor 23 and risk of cardiovascular disease: results from the EPIC-Germany case-cohort study
- (2014) Romina di Giuseppe et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia
- (2014) Thomas O. Carpenter et al. JOURNAL OF CLINICAL INVESTIGATION
- The fibroblast growth factor-23 and Vitamin D emerge as nontraditional risk factors and may affect cardiovascular risk
- (2014) S. Masson et al. JOURNAL OF INTERNAL MEDICINE
- Klotho and Phosphate Are Modulators of Pathologic Uremic Cardiac Remodeling
- (2014) M. C. Hu et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Plasma FGF23 and the risk of stroke: The Northern Manhattan Study (NOMAS)
- (2014) C. B. Wright et al. NEUROLOGY
- Dynamic regulation of FGF23 by Fam20C phosphorylation, GalNAc-T3 glycosylation, and furin proteolysis
- (2014) V. S. Tagliabracci et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fibroblast Growth Factor‐23 and Incident Coronary Heart Disease, Heart Failure, and Cardiovascular Mortality: The Atherosclerosis Risk In Communities Study
- (2014) Pamela L. Lutsey et al. Journal of the American Heart Association
- Fibroblast Growth Factor–23 and Cardiac Structure and Function
- (2014) Isha Agarwal et al. Journal of the American Heart Association
- Circulating Fibroblast Growth Factor‐23 and the Incidence of Atrial Fibrillation: The Atherosclerosis Risk in Communities Study
- (2014) Alvaro Alonso et al. Journal of the American Heart Association
- Alpha Klotho and phosphate homeostasis
- (2014) A. Bian et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophy
- (2013) Chad D. Touchberry et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- The Associations of Fibroblast Growth Factor 23 and Uncarboxylated Matrix Gla Protein With Mortality in Coronary Artery Disease: The Heart and Soul Study
- (2013) Benjamin D. Parker ANNALS OF INTERNAL MEDICINE
- Fibroblast Growth Factor 23 and Klotho: Physiology and Pathophysiology of an Endocrine Network of Mineral Metabolism
- (2013) Ming Chang Hu et al. Annual Review of Physiology
- FGF23: A Mature Renal and Cardiovascular Risk Factor?
- (2013) Carmine Zoccali et al. BLOOD PURIFICATION
- Serum FGF23 and Risk of Cardiovascular Events in Relation to Mineral Metabolism and Cardiovascular Pathology
- (2013) J. Arnlov et al. Clinical Journal of the American Society of Nephrology
- Use of phosphate binders in chronic kidney disease
- (2013) Markus Ketteler et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Plasma Fibroblast Growth Factor 23, Parathyroid Hormone, 25-Hydroxyvitamin D3, and Risk of Heart Failure: A Prospective, Case-Cohort Study
- (2013) Romina di Giuseppe et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of Klotho deficiency
- (2013) Rika Jimbo et al. KIDNEY INTERNATIONAL
- Association between Circulating Fibroblast Growth Factor 23, α-Klotho, and the Left Ventricular Ejection Fraction and Left Ventricular Mass in Cardiology Inpatients
- (2013) Kensaku Shibata et al. PLoS One
- Modulation of Cardiac Contractility by the Phopholamban/SERCA2a Regulatome
- (2012) Evangelia G. Kranias et al. CIRCULATION RESEARCH
- FGF23 neutralization improves chronic kidney disease–associated hyperparathyroidism yet increases mortality
- (2012) Victoria Shalhoub et al. JOURNAL OF CLINICAL INVESTIGATION
- Fibroblast Growth Factor-23 and Death, Heart Failure, and Cardiovascular Events in Community-Living Individuals
- (2012) Joachim H. Ix et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Update on fibroblast growth factor 23 in chronic kidney disease
- (2012) Myles Wolf KIDNEY INTERNATIONAL
- Higher fibroblast growth factor-23 increases the risk of all-cause and cardiovascular mortality in the community
- (2012) Johan Ärnlöv et al. KIDNEY INTERNATIONAL
- Cardioprotection by Klotho through downregulation of TRPC6 channels in the mouse heart
- (2012) Jian Xie et al. Nature Communications
- Plasma fibroblast growth factor 23, parathyroid hormone, phosphorus, and risk of coronary heart disease
- (2011) Eric N. Taylor et al. AMERICAN HEART JOURNAL
- Relation of Sex and Estrogen Therapy to Serum Fibroblast Growth Factor 23, Serum Phosphorus, and Urine Phosphorus: The Heart and Soul Study
- (2011) Joachim H. Ix et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- The phosphatonin fibroblast growth factor 23 links calcium–phosphate metabolism with left-ventricular dysfunction and atrial fibrillation
- (2011) Sarah Seiler et al. EUROPEAN HEART JOURNAL
- FGF23 induces left ventricular hypertrophy
- (2011) Christian Faul et al. JOURNAL OF CLINICAL INVESTIGATION
- Current challenges in the clinical management of hypertension
- (2011) Luis M. Ruilope Nature Reviews Cardiology
- Lanthanum carbonate reduces FGF23 in chronic kidney disease Stage 3 patients
- (2011) E. Gonzalez-Parra et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Anti-FGF-23 neutralizing antibodies ameliorate muscle weakness and decreased spontaneous movement of Hyp mice
- (2010) Yukiko Aono et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Spontaneous Ca waves in ventricular myocytes from failing hearts depend on Ca2+-calmodulin-dependent protein kinase II
- (2010) Jerry Curran et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Low Socioeconomic Status Associates with Higher Serum Phosphate Irrespective of Race
- (2010) O. M. Gutierrez et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Forging Forward with 10 Burning Questions on FGF23 in Kidney Disease
- (2010) M. Wolf JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population
- (2009) Majd A.I. Mirza et al. ATHEROSCLEROSIS
- Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease
- (2009) Orlando M. Gutiérrez et al. CIRCULATION
- Therapeutic Effects of Anti-FGF23 Antibodies in Hypophosphatemic Rickets/Osteomalacia*
- (2009) Yukiko Aono et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Anti-FGF23 Neutralizing Antibodies Show the Physiological Role and Structural Features of FGF23
- (2008) Yuji Yamazaki et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The Klotho gene family as a regulator of endocrine fibroblast growth factors
- (2008) Hiroshi Kurosu et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
- (2008) Orlando M. Gutiérrez et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search